Back to Index
David Y. Ko, MD
Associate Professor of Clinical Neurology
GNH A4e Off Campus Los Angeles
+1 323 409 7371


Krishnan R, Ko D, Foster CE, Liu W, Smink AM, de Haan B, De Vos P, Lakey JR. Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials. Methods Mol Biol. 2017; 1479:305-333. View in: PubMed

Ko D, Yang H, Williams B, Xing D, Laurenza A. Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies. Epilepsy Behav. 2015 Jul; 48:45-52. View in: PubMed

Ko D, Ramsay RE. Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures. Acta Neurol Scand Suppl. 2013; (197):36-43. View in: PubMed

Rison RA, Ko DY. Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. Clin Neurol Neurosurg. 2009 Jul; 111(6):558-61. View in: PubMed

Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Gilmore W, Cheema GS, Stohl W, Burnett ME, Ko D, Kachuck NJ, Weiner LP. Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol. 2004 Oct; 155(1-2):161-71. View in: PubMed

Ko DY. Clinical evaluation of patients with head trauma. Neuroimaging Clin N Am. 2002 May; 12(2):165-74. View in: PubMed

Powered bySC CTSI